Results 231 to 240 of about 4,991,463 (296)

Transformative therapies for sickle cell disease. [PDF]

CMAJ
Jamani K, Chopek A, Kumar R, Guilcher GMT.   +3 more
europepmc   +1 more source

Cracking the cytokine code in sickle cell disease: Immune‐informatics for precision inflammation mapping, risk prediction and therapeutic discovery

Clinical and Translational Discovery, Volume 6, Issue 5, October 2026.
Sickle cell disease inflammation emerges from interconnected cytokine networks. Immune‐informatics integrates multi‐omics, network biology and artificial intelligence to decode inflammatory signatures, predict complications and identify precision therapeutic targets. Abstract Background Sickle cell disease (SCD) is characterised by chronic inflammation
Emmanuel Ifeanyi Obeagu, Chukwuma J. Okafor   +1 more
wiley   +1 more source

Should Sickle Cell Disease Be Considered a Cancer Predisposition Syndrome? [PDF]

Children (Basel)
Casadessus E, Pastore Y, Pincez T.
europepmc   +1 more source

Supporting Digital Agriculture Through GeoAI: A Crop Type Dataset of Four Food Basket Crops in Rwanda

Geoscience Data Journal, Volume 13, Issue 4, October 2026.
A harmonised, GeoAI‐ready crop type dataset comprising 2739 georeferenced field points and 914 labelled polygons across four Rwandan districts addresses critical data gaps for model calibration and validation. This open, agronomically rich dataset strengthens digital agriculture, crop monitoring and food security efforts in Rwanda and sub‐Saharan ...
Benson Kenduiywo, Stephen Sande, Anastasia Wahome, Joseph Chemutt, Ange Marie Tesire, Samuel Ishimwe, Yves Hategekimana, Lilian Ndungu, Golo Rademacher, Aniruddha Ghosh   +9 more
wiley   +1 more source

Effectiveness of health care transition interventions for sickle cell disease. [PDF]

Blood Adv
Azul M, Aurora T, Porter J, Anderson S, Nelson M, Ogu UO, Rai P, Persaud Y, Longoria J, Heitzer A, Barton M, Olufadi Y, Baumann AA, Kang G, Hankins JS.   +14 more
europepmc   +1 more source

Identification of Clinical Sub-Phenotypes of Sickle Cell Disease Using Latent Class Analysis. [PDF]

Am J Hematol
Willen SM, Brunson AM, Adesina OO, Wun T.   +3 more
europepmc   +1 more source

Subtotal Versus Total Splenectomy in Children With Sickle Cell Disease: Clinical Outcomes and Splenic Function Assessed by Pocked Red Blood Cell Count

American Journal of Hematology, Volume 101, Issue 10, Page 2654-2658, October 2026.
Alma Al Sibaaie, Abdoulaye Sissoko, Carmen Capito, Christophe Chardot, Mariane de Montalembert, Valentine Brousse, Joséphine Brice, Martina Bevacqua, Camille Roussel, Lucie Dumas, Astan Cissé, Pierre Buffet, Slimane Allali   +12 more
wiley   +1 more source

Spirometry Patterns in Adult Sickle Cell Disease: A Retrospective Observational Study. [PDF]

Saudi J Med Med Sci
Almusally RM, Alghamdi R, Almubarak M, Ibrahim M, Alyousif H, Alelq Z, Alwaheed A, Alsultan O, Alsaeed A, Qutub H, Wert Y, Aljazeeri J.   +11 more
europepmc   +1 more source

A Multicenter, Open‐Label, Phase 2 Trial Comparing Crizanlizumab Combined With Standard Therapy to Standard Therapy Alone on Renal Function in Patients With Sickle Cell Nephropathy (STEADFAST)

American Journal of Hematology, Volume 101, Issue 10, Page 2666-2671, October 2026.
Kenneth I. Ataga, Pablo Bartolucci, Santosh L. Saraf, Vimal K. Derebail, Adlette Inati, Jeffrey D. Lebensburger, Laurie DeBonnett, Rodolfo D. Cancado, Claire C. Sharpe   +8 more
wiley   +1 more source

UGT1A1 polymorphisms and gallbladder-related outcomes in sickle cell disease in Brazil. [PDF]

Ann Hematol
Costa FF, Fertrin KY.
europepmc   +1 more source